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at safety net public hospitals is associated with
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Objective: This study compared in-hospital mortality and resource utilization among vascular surgical patients at safety net
public hospitals (SNPHs) with those at nonsafety net public hospitals (nSNPHs).
Methods: TheNational Inpatient Sample (2003-2011)wasqueried to identify surgical patientswith peripheral arterial disease
(PAD), carotid stenosis, or nonruptured abdominal aorta aneurysm based on International Classiﬁcation of Diseases, Ninth
Revision,ClinicalModiﬁcationdiagnostic andprocedure codes. The cohortwas thendivided into SNPHandnSNPHgroups
according to the deﬁnition of SNPH used by the National Association of Public Hospitals. Clinical characteristics, length of
stay, in-hospitalmortality, andhospital chargeswere comparedbetweengroups.AdvancedPADwasdeﬁnedas that associated
with rest pain or tissue loss. Statistical methods included bivariate c2 tests for categoric variables, t-tests for continuous
variables, and multivariable linear and logistic regression to adjust for confounding variables (in-hospital mortality).
Results:We identiﬁed 306,438 patients operated on for PAD, carotid stenosis, and abdominal aortic aneurysm. Patients at
SNPHs were younger, the percentage of female and minority patients was higher, and patients had a higher Elixhauser
comorbidity index (P < .001). Nonelective admissions were more common among SNPH patients who presented with
more advanced PAD (P > .05) and symptomatic carotid stenosis (P < .05). Patients at SNPHs had a signiﬁcantly longer
length of stay, higher hospital charges, and higher in-hospital mortality (P < .05 for all variables). Crude odds of mortality
at SNPHs were 1.28 higher than at nSNPHs (95% conﬁdence interval, 1.13-1.46; P < .001), but adjusted analyses
revealed no statistically signiﬁcant difference between the odds of in-hospital mortality at both hospital groups.
Conclusions: Patients undergoing vascular surgery at SNPHs, despite being younger, had higher comorbidities, presented
more urgently with more advanced disease, and incurred higher costs than the SNPH cohort despite similar adjusted odds
of in-hospital mortality. Delayed presentation and higher comorbidities are most likely related to poor access to routine
and preventive health care for the SNPH patients. (J Vasc Surg 2014;60:1627-34.)Access to care affects surgical outcomes.1 In patients
with peripheral arterial disease (PAD), many studies have
shown a decrease in amputation rates associated with
appropriate primary care evaluation and timely referral to
a vascular surgeon for aggressive wound care and revascu-
larization.2,3 Sociodemographic factors, including age, in-
come, race, gender, and insurance payer status adversely
affect access to care and have been shown to lead to an
increased rate of amputation among patients with PAD.4
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(AAA).6,7 We have demonstrated that Medicaid recipients
had a 1.7-fold higher odds of presenting with a ruptured
AAA than patients with private insurance.7 Although spe-
ciﬁc causation may be difﬁcult to delineate using large
population-based studies, lack of appropriate primary care
has been hypothesized to lead to delayed diagnosis and
adverse outcomes.8
Safety net public hospitals (SNPHs) are institutions
that have a higher share of sociodemographically chal-
lenged patients.9 These hospitals are have an “open
door” policy of offering services to patients regardless of
their capability to pay9 and also have a substantial payer
mix of uninsured and Medicaid beneﬁciaries.9 Such hospi-
tals by “mission or by mandate” provide disproportionate
care to “vulnerable patients.”9 Although the deﬁnition of
a “vulnerable patient” is not clearly delineated, it includes
low-income patients and Medicaid recipients.9
Given the association of Medicaid insurance and unin-
sured status on presentation and outcomes,7 we set out to
assess whether outcomes of patients undergoing vascular
surgery procedures are different at SNPHs and non-
SNPHs (nSNPHs). As such, we compared clinical presen-
tation, in-hospital mortality, hospital length of stay (LOS),
and overall hospital charges for patients treated for intact1627
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institutions.
METHODS
To compare surgical outcomes at SNPHs and
nSNPHs, we evaluated the National Inpatient Sample
(NIS) for 2003 to 2011. The NIS is the largest database
of its kind and includes all payer discharge information
from a national survey of 20% of all nonfederal hospitals
in the United States. A complete overview and description
of the NIS is available on its Web site.10 The NIS was
queried to identify patients undergoing open repair of
intact (nonruptured) AAA, carotid endarterectomy
(CEA), and lower extremity bypass (LEB) by linking the
International Classiﬁcation of Disease, Ninth Revision,
Clinical Modiﬁcation (ICD-9-CM) procedure codes11 for
all patient discharges associated with a primary diagnosis
of intact AAA, carotid stenosis, and PAD. We excluded pa-
tients with ruptured AAA.
The Boston University School of Medicine Institu-
tional Review Board approved the use of deidentiﬁed
data for this study. Given that this is a deidentiﬁed data-
base, no patient consent was obtained.
The NIS reports the median income for each patient’s
postal ZIP code, allowing the use of these data as a proxy
for each patient’s socioeconomic status. We deﬁned
SNPHs as hospitals for which >25% of the patients
were derived from the lowest income ZIP codes using
one of the deﬁnitions used for SNPH9 (Fig 1). The pa-
tient cohort was then divided into patients treated at
SNPHs and nSNPHs.
Primary outcomes of interest, including in-hospital
mortality, and resources utilization, including hospital
charges and LOS, were then compared between the two
hospital types. These primary outcomes included in-
hospital mortality and resources utilization, which included
charges and LOS. Detailed procedure cost information is
unavailable in the NIS; therefore, total hospital charges
were used as a surrogate for cost information.
The NIS provides a weighting strategy to draw esti-
mates at the national level based on a 20% annual survey
of hospitals. Statistical analyses were performed based on
these weighted numbers, and therefore, values provided
in the Results, unless speciﬁed otherwise, are representative
of the national values. This use of survey weights to make
observations regarding surgical procedures at the national
level is a method that has been previously described.12,13
Data points with missing data for in-hospital mortality
were removed from the analysis.
Bivariate comparisons of categoric variables were per-
formed using c2 tests, and continuous variables were
compared by t-tests. LOS and hospital charges were log-
transformed for the analysis. Institutional volumes and
surgeon case volumes have been shown to be an indicator
of mortality in many studies for a variety of different proce-
dures14,15; however, a unique surgeon identiﬁer is not
available for most NIS states, so surgeon volume was not
included in this study.To evaluate the causes of disparity of crude mortality,
in addition to differences in comorbidities, we compared
the hospital volume compositions of these two cohorts
during each year of our study. We divided each cohort
into three volume groups by the number of annual AAA
operations performed at each hospital type based on the
Leapfrog group recomendations16 as low (<30 per
annum), medium (30-49 per annum), and high (>50 per
annum) volume category hospitals.
Multivariable logistic regression, which adjusts for con-
founding variables, was performed to determine whether
the type of hospital was associated with a higher odds ratio
(OR) of in-hospital mortality. For covariate-adjusted
testing of differences in hospital cost and LOS between
the two hospital types, a parametric multivariable regres-
sion was used after log-transformation of hospital cost
and LOS.
Covariates included in the logistic regression for mor-
tality included patient age, gender, insurance type, and
the comorbid conditions of hypertension, diabetes melli-
tus, chronic lung disease, coronary artery disease, conges-
tive heart failure (CHF), valvular heart disease, obesity,
and renal failure. Many studies have shown that these vari-
ables affect mortality rates of vascular procedures and are
generally agreed to be risk factors for mortality.
Statistical analyses were performed using SAS 9.3 soft-
ware (SAS Institute Inc, Cary, NC). The Elixhauser comor-
bidity SAS macro, designed for use with administrative data
sets, was used to identify patient comorbidities for the pur-
poses of bivariate and multivariable analyses.17 Elixhauser
software includes the ICD-9-CM codes for the comorbid-
ities of interest. These ICD-9-CM codes are included in
the Appendix. A P < .05 was considered statistically signif-
icant for all tests.
RESULTS
In the NIS during the calendar years 2003 to 2011, we
identiﬁed 306,438 patients with discharge diagnoses of
intact AAA, LEB, and CEA. Most patients were not treated
at SNPHs (9.56% vs 90.4% at nSNPHs). This corresponds
appropriately with the observation here that <14.0% of
hospitals were SNPHs during each year of this study. A
signiﬁcantly higher representation of teaching hospitals
was among SNPHs than nSNPHs during each year of
this analysis (P < .05). SNPHs performed 9.6% of all
AAA procedures, 8.8% of all CEA procedures, and
12.04% of LEB procedures. Proportionately higher per-
centages of SNPH patients were Medicaid beneﬁciaries.
Table I provides a descriptive comparison between patients
treated at SNPHs and nSNPHs.
Analysis of patient characteristics, presentations,
and type of admission. The national estimates based on
SNPH and nSNPH patient groups showed signiﬁcant dis-
similarities in age, gender, and racial composition. The pa-
tient population at SNPHs was signiﬁcantly younger
(P < .001) and composed of a proportionately higher per-
centage of women (P ¼ .044) and nonwhite (P < .001)
patients.
Fig 1. Schematic drawing of the analyses described here. The National Inpatient Sample (NIS) was linked using
International Classiﬁcation of Disease-Ninth Revision (ICD-9) codes to identify patients who were treated for
abdominal aorta aneurysm (AAA) or underwent carotid endarterectomy (CEA) or a lower extremity bypass (LEB) in a
safety net public hospital (SNPH) or in a nonsafety net public hospital (n-SNPH).
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ulation had a signiﬁcantly higher percentage of patients
with CHF (P < .001), renal failure (P < .001), history
of PAD (P < .001) and diabetes mellitus (P < .001).
The rates of chronic obstructive pulmonary disease and hy-
pertension were not statistically different between the two
populations. The Elixhauser comorbidity index was signif-
icantly higher among patients at SNPHs compared with
those at nSNPHs (Table I).
We also compared the frequency of some of the social
maladies recognized as contributing to the overall
complexity of postoperative care and therefore affecting
mortality and LOS. Alcohol abuse and drug abuse were
signiﬁcantly higher among the SNPH patients (P < .001).
Severity of presentation and type of admissions were
also compared between the two populations. Within the
comparison of patients with symptomatic carotid stenosis
(ICD-9-CM code 433.11) and advanced PAD (ICD-9-
CM codes 440-22 to 440-24), those with symptomatic ca-
rotid stenosis were signiﬁcantly more commonly treated at
SNPHs than at nSNPHs (5.4% vs 3.6%; P< .001). Patients
with advanced PAD, with codes corresponding to rest pain
(440.22), PAD with ulceration (440.23), and PAD with
gangrene (440.24), were similarly compared at these two
hospital types (Table I). This difference was not statistically
signiﬁcant (P ¼ .061). The frequency of the types of AAA
repair was similar across the hospital groups (Table I), with
endovascular AAA repair constituting the most common
type of AAA repair for both of these hospital cohorts.
However, the rate of nonelective admissions was signiﬁ-
cantly higher at SNPHs (24.6%) than at nSNPHs
(16.7%; P < .001).
Unadjusted analysis of patient postoperative mor-
tality. The crude mortality rates were signiﬁcantly higher
for SNPH patients (0.9%) than for nSNPH patients (0.8%;P ¼ .020). When stratiﬁed by procedure, crude in-hospital
mortality rates for AAA (2.1% vs 1.8%; P ¼ .178) and
CEA (0.4% vs 0.3%; P ¼ .093) were higher at SNPHs, but
these differences were not statistically signiﬁcant. In-hospital
mortality rates for LEB were identical in these hospital
group populations (1.1% vs 1.1%; P ¼ .999; Fig 2).
Unadjusted analysis of hospital charges and LOS.
Treatment of the overall sample was associated with a me-
dian charge of $27,556 and median LOS of 2 days. The
population estimates of mean hospital charges were signif-
icantly higher at SNPHs ($52,316 6 $2174.9 vs
$41,239 6 $676.2; P < .001). Mean LOS was also signif-
icantly longer (4.4 6 0.1 vs 3.5 6 0.01; P < .001) for the
SNPH patients. The mean charges and LOS are presented
in Fig 3.
Comparisons of volume characteristics between
hospitals. Comparison of SNPH and nSNPH populations
revealed that, overall, the volume between the two cohorts
did not differ signiﬁcantly except for 2 years, 2006 and
2009 (Table II). More than 80% of all hospitals in both
groups did not achieve the standards set for AAA repair by
the Leapfrog Group (>50 AAA per year)16 every year. For
only 3 years among the nSNPHs and 1 year among the
SNPHs did 10% of each group surpass the standard. Most
of the hospitals in both cohorts were considered to be low-
volume centers (Table II).
Multivariable analysis of in-hospital mortality.
Multivariable logistic regression that adjusts for the con-
founding variables, patient care at SNPH, was not signiﬁ-
cantly associated with higher mortality. The odds of
mortality were not increased at SNPHs compared with
nSNPHs (Fig 2). Stratiﬁed by the procedure types,
adjusted analyses also revealed no statistically signiﬁcant
differences between the two hospitals and across the three
procedures. Fig 4 is a plot of ORs in the multivariable
00.5
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Fig 2. Comparisons of in-hospital mortality rates between safety net public hospitals (SNPHs) and nonsafety net public
hospitals (nSNPHs). A, Depicts the crude mortality rates between the two hospital types. B, Depicts the multivariable
analyses of the two cohorts. AAA, Abdominal aorta aneurysm; CEA, carotid endarterectomy; CI, conﬁdence interval;
LEB, lower extremity bypass; OR, odds ratio; Overall, overall samples.
Table I. A summary of the analyses of patients who were treated for peripheral arterial disease (PAD), abdominal aorta
aneurysm (AAA), or carotid stenosis (CS) at safety net public hospitals (SNPHs) compared with those treated at nonsafety
net public hospitals (nSNPHs)
Characteristics SNPH (n ¼ 29,300) nSNPH (n ¼ 277,138) P value
Demographics
Age, mean 6 SE, years 69.7 6 0.2 71.2 6 0.1 <.001
Female gender, % 38.2 37.2 .044
Nonwhite race, % 27.8 11.5 <.001
Comorbidities, %
CHF 7.6 6.8 .001
Hypertension 68.2 67.3 .211
Diabetes 31.9 28.6 <.001
Renal failure 3.8 2.9 <.001
History of PAD 23.6 22.6 .145
Chronic pulmonary disease 24.1 24.3 .595
Drug abuse 0.6 0.2 <.001
Alcohol abuse 1.9 1.5 <.001
Elixhauser Index, mean 6 SE 2.14 6 0.02 2.06 6 0.01 <.001
Presentation and type of operation, %
Advanced PAD 58.3 55 .061
Symptomatic CS 5.4 3.6 <.001
Endovascular AAA repair 74.6 72.6 .132
Nonelective admissions 24.6 16.7 <.001
Primary payer, %
Medicaid 6.9 2.5 <.001
Medicare 68.2 73.2
Private (including HMO) 19 21.8
Other 5.9 2.4
CHF, Congestive heart failure; HMO, health maintenance organization; SE, standard error.
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by procedures. Factors that affect the in-hospital mortality
included nonwhite vs white race (OR, 1.37, 95% conﬁ-
dence interval, 1.22-1.54; P < .001) and the type of
admissions, with nonelective admissions increasing theodds of mortality by 2.24-fold (OR, 2.24; 95% conﬁdence
interval [CI], 2.04-2.46; P < .001).
Multivariable analysis of resources utilization.
Adjusted comparison of hospital charges revealed that the
charges were signiﬁcantly higher for SNPHs after adjusting
Mean Charges
(Overall)
Mean Charges
(LEB;$)
Mean Charges
(CEA;$)
Mean Charges
(AAA;$)
SNPH nSNPH
*            *    
*
*
P<0.05
Mean LOS
(Overall;
days)
Mean LOS
(LEB; days)
Mean LOS
(Carotid; d)
Mean LOS
(AAA; days)
SNPH
nSNPH
A B
Fig 3. Comparison of in-hospital (A)mean charges and (B)mean length of stay (LOS) between the between the safety
net public hospital (SNPH) and nonsafety net public hospitals (nSNPH) cohorts. AAA, abdominal aortic aneurysm;
CEA, carotid endarterectomy; LEB, lower extremity bypass.
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tion with the signiﬁcantly higher LOS at SNPHs
(P ¼ .007) resulted in resources utilization that was signif-
icantly higher at the SNPHs.
DISCUSSION
In this retrospective observational study of contempo-
rary national data (2003-2011), we found that hospitals
deﬁned as SNPHs provided care to a proportionately higher
portion of women, minorities, andMedicaid recipients. The
patient cohort at the SNPHs had signiﬁcantly higher comor-
bidities rates and higher Elixhauser indices. The rate of
nonelective admissions was also signiﬁcantly higher at
SNPHs. In terms of resources utilization, median total hos-
pital charges were signiﬁcantly greater for the SNPH pa-
tients ($35,800 vs $26,751), and mean LOS was also
longer (4.4 6 0.1 vs 3.5 6 0.01 days) than for the nSNPH
patients. Hospital volume compositions were not signiﬁ-
cantly different between the two cohorts, although nSNPHs
had higher proportions of high-volume AAA centers than
SNPHs in all except 1 year of this study. Multivariable ana-
lyses of in-hospital mortality rates for the procedures studied
here revealed that, despite higher crude mortality rates at
SNPHs (0.8% vs 0.9%; P< .001), in-hospital mortality rates
were comparable between these two cohorts after adjusting
for all of the confounding variables.
Vascular maladies are often asymptomatic (eg, carotid
stenosis or AAA) or have similar signs and symptoms to
other common and well-known conditions (eg, claudica-
tion vs arthritis). Recognizing vascular abnormalities thus
often requires a focused vascular physical examination or
speciﬁc tests, or both. Given the occult nature of these
vascular entities, the lack of access to adequate primary
care would be expected to contribute to a delay in the diag-
nosis of a vascular condition and timely referral to a
vascular surgeon. Access to adequate primary care hasbeen observed to lead to better outcomes18,19 for all med-
ical conditions, as a whole. Factors such as insurance status,
race, gender, income, and other socioeconomic factors
affect access and therefore outcomes of vascular conditions
speciﬁcally.1,4,7,19
According to the latest publication of the Agency for
Healthcare Research and Quality on disparity of
care, <70% of low-income patients had medical insur-
ance20 in 2012. The SNPHs by mandate or decree take
care of this patient cohort.9 By deﬁnition, SNPHs have
>20% low income patients or have twice the state average
of the Medicaid recipients, or both.9 In this study, our deﬁ-
nition of SNPH proved to be accurate, because the patient
composition at hospitals designated as SNPHs included
twice as many Medicaid beneﬁciaries as those designated
as nSNPH.
Although this study did not allow for a temporal
follow-up of these patients due to the limitations of the
NIS database, we found that the rate of symptomatic ca-
rotid stenosis was signiﬁcantly higher at SNPHs, possibly
suggesting a delayed presentation of these patients. This
ﬁnding is similar to the observation of a signiﬁcantly higher
rate of symptomatic CEA among minorities by Schneider
et al.5 Previously, we7 and other authors6 observed that be-
ing a Medicaid beneﬁciary was an independent factor pre-
dicting presentation with a ruptured AAA. Presentation of
gangrene, the most advanced stage of PAD, was also more
common among minorities and patients of low socioeco-
nomic status.4 These observations, along with the ﬁndings
of the current study, suggest that low-income patients
often present in a delayed fashion. In addition, the current
study showed that nonelective admissions constituted
w25% of the procedures at SNPH, which is signiﬁcantly
higher than the 16.7% frequency of such cases at nSNPHs.
Nonelective admission was also an independent factor of
mortality in this cohort, increasing the odds of mortality
Table II. Annual volume characterization at safety net public hospitals (SNPHs) and nonsafety net public hospitals
(nSNPHs)a
Year
SNPH nSNPH
P valueLow (%) Medium (%) High (%) Low (%) Medium (%) High (%)
2003 84.6 10.3 5.1 82.8 10.1 7.1 .999
2004 87.0 4.3 8.7 82.7 11.0 6.3 .296
2005 90.7 7.0 2.3 78.4 14.7 6.9 .219
2006 93.1 6.9 0.0 78.6 10.4 11.0 .006
2007 87.2 8.5 4.3 77.5 10.8 11.7 .260
2008 82.6 10.9 6.5 74.1 14.8 11.1 .556
2009 92.2 5.9 1.9 70.6 18.0 11.3 .004
2010 84.9 7.6 7.5 79.6 11.5 8.9 .760
2011 77.6 10.2 12.2 76.7 15.7 8.6 .500
aVolume characterization is based on the annual abdominal aortic aneurysm (AAA) volumes as low, <20; medium, 20-50; and high >50.
Fig 4. Multivariable analysis of factors affecting in-hospital mortality. No difference was noted in the odds ratio (OR)
of mortality of patients treated at safety net public hospitals (SNPHs) and those treated at nonsafety net public hospitals
(nSNPHs). CI, Conﬁdence interval.
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vations for other medical conditions.21
A signiﬁcantly higher number of urgent cases, signiﬁ-
cantly more comorbidities, and delayed presentation at
SNPHs are likely to be important contributors of increased
crude mortality rates at SNPHs rather than the quality of
care at these institutions. We disagree with the observations
in this regard made by Mouch et al,22 who reviewed the
literature and concluded that the quality of surgical care
is worse at SNPHs. Factors that authors considered as
the metrics of quality care are outlined by the Institute of
Medicine.23 These measures are deﬁned by the Institute
of Medicine as safety, timeliness of care, effectiveness of
care, patient centeredness, and equity of care.23 Ultimately,
these measures affect mortality.
We, therefore, suggest that a more accurate and useful
metric to assess quality of care in patients undergoing
vascular surgery is mortality rate. Patients at SNPHs weresicker, presented in a more delayed fashion, and had
more comorbidities than their nSNPH cohorts. Adjusted
analyses between these cohorts, despite the previously
mentioned higher medical acuity of these patients, showed
no increase in odds of mortality in patients undergoing
vascular surgery at SNPHs compared with nSNPHs. In
this regard, our study is similar to the studies of Ross
et al24 and Marshall et al,25 who found no differences in
outcomes among such hospitals.
One signiﬁcant difference between the hospital cohorts
was resource utilization. Although speciﬁc costs cannot be
measured due to limitations of the NIS, median charges
and LOS were both signiﬁcantly higher at SNPHs. We
believe that LOS is directly associated with the higher
complexity of SNPH patients and the higher rate of
nonelective cases. In addition to the signiﬁcantly higher
risk of mortality with unplanned operations,21,26 other au-
thors have observed a signiﬁcant increase in the cost of care
JOURNAL OF VASCULAR SURGERY
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planned procedures. In a study by Ho et al,28 preoperative
factors that independently affected extended LOS included
female gender, CHF, and chronic obstructive pulmonary
disease. All three of these factors were more prominent
among SNPH patients in the current study.
Another signiﬁcant barrier to timely discharge from the
hospital is access to appropriate posthospital acute care fa-
cilities, which is independently affected by the insurance
payer status.29 We suggest that the preoperative comorbid-
ities, social maladies, and lack of access to adequate post-
hospital acute care facilities lead to delayed discharges of
SNPH patients and a signiﬁcantly longer LOS, and conse-
quently, higher charges at these institutions. In any discus-
sion about quality of care, it is therefore imperative to
refrain from using costs as a sole quality measure when
comparing SNPHs and nSNPHs.
Limitations of studies using administrative data sets
such as the NIS have been described previously.30 Coding
inaccuracies in patient case-mix, including prevalence of
comorbidities, or race is possible. To minimize these inac-
curacies, we used established comorbidity software to
attempt to appropriately characterize patients with pre-
existing comorbid conditions.17
In addition, in-hospital outcomes are a suboptimal
measure of overall success when evaluating surgical inter-
ventions. Ideally long-term information, such as 30-day
and 1-year mortality rates, would be used. However due
to the arduous patient deidentiﬁcation process used by
the NIS, follow-up information is unavailable. In this
regards, NIS database does not allow comparisons of read-
missions between two hospital cohorts. Similarly, total hos-
pital charges as a marker of the economic effect of a surgical
procedure provides only crude information. This study
used total hospital charges as a surrogate for cost informa-
tion, and therefore, conclusions should be drawn bearing
this in mind. Previous studies have used this total hospital
charge information,31 which was corroborated with institu-
tional studies and mitigates this limitation to some degree,
suggesting that hospital charges is a reasonable surrogate of
procedure costs.
One other limitation of NIS is speciﬁc to the use of the
database in assessing the percentage of symptomatic CEA
procedures recorded in this database.32 Because we
compared the two samples from the same database with
each other, it is difﬁcult to imagine the mitigating short-
comings of NIS was done in a biased fashion favoring
one cohort over the next.
Despite these limitations, we believe that our analysis
adequately compares the most important outcome of inter-
est after a vascular surgical procedure: in-hospital mortality
rates. This study suggests that mortality rates are compara-
ble between the two hospital types despite the many differ-
ences between these patient cohorts.
Ultimately, universal access to insurance, as mandated
by the implementation of the Affordable Care Act, may in-
crease insurance availability and thus improve outcomes by
removing some of the barriers to care that SNPH patientsand providers face. But concurrently, it may also increase
the volume of care at these institutions that patients of
lower socioeconomic status use for their care. This may
further tax the already limited resources at SNPHs. As
quality metrics become an integral component of reim-
bursing patients’ care, it is important to recalibrate the
quality metrics for SNPHs and avoid “one size ﬁts all”
quality metrics. Metrics that are used to measure quality
of care at SNPHs must account for the sociodemographic
variability and the medical and social complexities of the
socioeconomically vulnerable patients who receive their
care at SNPHs.
CONCLUSIONS
This study suggests that despite higher comorbidities
and disadvantages in the variation of volume compositions
at SNPHs, vascular surgery patients at SNPHs receive com-
parable care as those patients cared for at nSNPHs. Higher
resource utilization at SNPH is a function of the higher
medical and social complexities of SNPH patients rather
than of the quality of surgical care received.
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